Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tüting

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Oncoimmunology|July 7, 2017
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionJulian P Layer, Marie T Kronmüller, Thomas Quast, et al.
Oncoimmunology|November 18, 2016
RIG-I activation induces the release of extracellular vesicles with antitumor activityJuliane Daßler-Plenker, Katrin S Reiners, Jasper G van den Boorn, et al.
Vaccine|January 29, 2011
Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccineBasav N Hangalapura, Dinja Oosterhoff, Tarun Gupta, et al.
International Journal of Cancer|September 5, 2008
Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skinJoerg Wenzel, Stefan Tomiuk, Sabine Zahn, et al.
Immunity|August 5, 2020
Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in MelanomaMaike Effern, Nicole Glodde, Matthias Braun, et al.
The Journal of Investigative Dermatology|June 22, 2007
Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic diseaseRegina C Betz, Jana Pforr, Antonia Flaquer, et al.
Cancer Immunology Research|May 5, 2017
RIG-I Resists Hypoxia-Induced Immunosuppression and DedifferentiationChristina Engel, Grethe Brügmann, Silke Lambing, et al.
European Journal of Immunology|December 3, 2005
Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDOGerhard Wingender, Natalio Garbi, Beatrix Schumak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Cancer Cell|August 4, 2009
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cellsDamià Tormo, Agnieszka Checińska, Direna Alonso-Curbelo, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Oncoimmunology|July 7, 2017
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionJulian P Layer, Marie T Kronmüller, Thomas Quast, et al.
Oncoimmunology|November 18, 2016
RIG-I activation induces the release of extracellular vesicles with antitumor activityJuliane Daßler-Plenker, Katrin S Reiners, Jasper G van den Boorn, et al.
Vaccine|January 29, 2011
Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccineBasav N Hangalapura, Dinja Oosterhoff, Tarun Gupta, et al.
International Journal of Cancer|September 5, 2008
Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skinJoerg Wenzel, Stefan Tomiuk, Sabine Zahn, et al.
Immunity|August 5, 2020
Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in MelanomaMaike Effern, Nicole Glodde, Matthias Braun, et al.
The Journal of Investigative Dermatology|June 22, 2007
Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic diseaseRegina C Betz, Jana Pforr, Antonia Flaquer, et al.
Cancer Immunology Research|May 5, 2017
RIG-I Resists Hypoxia-Induced Immunosuppression and DedifferentiationChristina Engel, Grethe Brügmann, Silke Lambing, et al.
European Journal of Immunology|December 3, 2005
Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDOGerhard Wingender, Natalio Garbi, Beatrix Schumak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Cancer Cell|August 4, 2009
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cellsDamià Tormo, Agnieszka Checińska, Direna Alonso-Curbelo, et al.
Pageof 16